Trial Profile
Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Squamous Cell Carcinoma (ESWN 01 Trial): a Phase 3, Prospective,Multicenter, Randomised Study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms ESWN 01
- 24 Dec 2014 New trial record